CPT 0091U: FirstSightCRC™ CTC and cfDNA Test for Colorectal Neoplasia
CPT code 0091U is a Proprietary Laboratory Analyses (PLA) code for the FirstSightCRC™ test from CellMax Life that isolates and analyzes circulating tumor cells (CTCs) and cell-free DNA (cfDNA) from a whole blood specimen and reports results as positive or negative for colorectal adenoma or cancer; service type: molecular diagnostic blood test (liquid biopsy); typical site of service: clinical laboratory or outpatient phlebotomy collection setting.
For related coverage guidance, see recent payer policy updates: RTM Testing of Homocysteine Metabolism-Related Conditions, Multimarker Serum Testing Related to Ovarian Cancer, Genomic Profiling for Selecting Targeted Cancer Therapies.
Customize your policy alerts
Sign up for cpt 0091U policy alerts
Get alerted when payer policies referencing 0091U are released or updated.
Monitor payer policy activity